Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Gold In Pre-Recession World

The yield curve has inverted. It suggests that we are about one year before the recession. How should the yellow metal behave in such a period? We invite you to read our today’s article and find out how gold is likely to behave in the pre-recession world. ...

U.S. GDP Accelerates, while Socialists Triumph in Spain. Will Gold also Win?

The US economic growth in the Q1 2019 positively surprised. Indeed, on the upside. The doubting Thomasses were proven wrong. And The Socialist Party just won the snap elections in Spain. Is the left back in vogue in the Eurozone? But what does it all mean for the gold market? ...

Gold, the Shining Star Among Commodities

Gold is the most effective commodity investment, yet it is under-invested, the WGC reports. What makes it special and deserving of our focus? And how to translate that focus into an appropriate allocation within one’s portfolio? Gold is Unique Commodity. Or…...

After Financing Close, Biotech's Subsidiary to Operate Independently

An H.C. Wainwright & Co. report explained the purpose of the funding and how any resulting developments would positively impact the former parent company. In a Feb. 22 research report, H.C. Wainwright & Co. analyst Ram Selvaraju reported that Inovio Pharmaceuticals In...

Gold Jumps Above $1,400 after Dovish Fed

Last week was definitely hot. Both major central banks adopted a more dovish stance. Gold reacted positively, jumping above $1,400. What has changed, and what has not? How close are we to an actual rate cut, not only to the speculation of getting one for sure on the next Fed m...

Company Named 'Top Small-Cap Growth Story'

The reasons for the positive outlook are given in a Raymond James report. In a July 3 research note, analyst Praveen Narra reported that Raymond James maintained its Strong Buy rating but reduced its target price on Newpark Resources Inc. (NR:NYSE) to ...

What ECB’s Tiering Means for Gold

In a key policy shift, the ECB has recently introduced tiered system of interest rates. This news isn’t of interest only to the banks keeping their reserves at the ECB. In today’s article, you’ll learn about the new instrument of...

Gold Projected to Beat the Market in 2020

Gold will outperform the S&P 500 Index in 2020. That’s one of several projections made by CLSA in its just-released “Global Surprises 2020” report. The Hong Kong investment firm has an impressive track record when it comes to maki...

Clinical Catalysts Impending for California-Based Biopharma

The firm's three upcoming potential stock movers are reviewed in a ROTH Capital Partners report. In a March 17 research note, ROTH Capital Partners analyst Zegbeh Jallah presented the events that could positively impact Turning Point Therapeutics Inc.'s (TP...

Pandemics and Gold: Part 2

Teaser: The outbreak of COVID-19 has brutally reminded people of the risk of a pandemic. However, investors should never panic but look to history as a guide. We invite you thus to read our today’s article, which provides an important analysis of the history ...
1 2 3 4 5 6 7 8 9 10 ...